ImCyse: Pfizer Renews Partnership for Next-Gen Approach to Autoimmune Disease
Pfizer struck a collaboration and licensing agreement with Belgium-based Imcyse for a rheumatoid arthritis program, which is based on that company's Imotope technology.
Read full article »
Imcyse is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of chronic autoimmune diseases.
Read more